Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3,975.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,825.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 0
  • Market Cap: 207.07m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
31-Dec-20 Interim 5.16 3.72 59.47p 43.00p

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-16 a5.52 a4.22 69.18p 13.9 0.4 +37% 42.50p 4.4%
30-Jun-17 7.25 5.77 96.36p 19.8 0.5 +39% 51.00p 2.7%
30-Jun-18 7.98 6.87 110.21p 26.7 1.9 +14% 61.00p 2.1%
30-Jun-19 9.29 6.97 114.04p 32.8 8.2 +4% 73.00p 2.0%
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 n/a n/a n/a n/a n/a -100% n/a 0.0%
30-Jun-22 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 29.77 13.91 24.59 1.16

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 3,975.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4,500.00
52 Week Low 3,825.00
Volume 0
Shares Issued 5.21m
Market Cap 207.07m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.15% below the market average84.15% below the market average84.15% below the market average84.15% below the market average84.15% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Price Trend
42.74% below the market average42.74% below the market average42.74% below the market average42.74% below the market average42.74% below the market average
6.45% below the sector average6.45% below the sector average6.45% below the sector average6.45% below the sector average6.45% below the sector average
Income Not Available
Growth
76.87% above the market average76.87% above the market average76.87% above the market average76.87% above the market average76.87% above the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for --2021

Time Volume / Share Price
0 @ 0.000p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page